Clinical Investigator

Qualifications:

  • Board in psychiatry and sexology.
  • Psychologist, M.A,
  • Certificate of therapist and supervisor in cognitive behavioural therapy

Professional registration:

(Name of body, registration number and date of registration.GMC or medical licence number)
  • Medical doctor registration number: 9735109

Previous and other appointments:

(Include previous appointments in the last 5 years and other current appointments.)
  • Head of the II Department of Psychiatry, Medical University of Warsaw
  • Consultant of Mazovia Provincial Psychiatric Hospital “Drewnica”

Research experience:

(Summary of research experience, including the extent of your involvement. Refer to any specific clinical or research experience relevant to the current application.)
  • 37 year of experience in research at university departments of psychiatry, last 20 years as the head.
  • Country coordinator in International multicenter studies: A multicentre, multinational, observational study of men with and without PE and their female partners conducted in 5 European countries. 2005 - 2008. Cross-national Diabetes Attitudes Wishes and Needs (DAWN) MIND study, 2008- Diabetes Attitudes Wishes and Needs (DAWN) 2.0 Study: A multinational, multi-stakeholder mixed method study of psychosocial issues in diabetes and patient-centered diabetes care. 2010- 2016.
  • Principal Investigator and Country Coordinator
  • 1998 - Schizophrenia. Phase III.
  • 2003 - Generalized anxiety disorder. Phase III.
  • 2007 - Major Depression with Inadequate Response to an Antidepressant Treatment. Phase III
  • Principal Investigator
  • 1999 - Major Depressive Disorder. Phase IV.
  • 2000 - Schizophrenia Phase III.
  • 2004 - Maintenance Treatment of Bipolar I Disorders in Adult Patients. Phase III.
  • 2005 - Acute Manic and Mixed Episodes associated with Bipolar I Disorder. Phase III.
  • 2006 - Schizophrenia or schizoaffective disorder. Phase III.
  • 2007 - Schizophrenia or Schizoaffective Disorder. Phase III.
  • 2008 - 2010 - Bipolar I Depression, Phase III.
  • 2011 - 2013 - Major Depression with Inadequate Response to an Antidepressant Treatment. Phase III.
  • 2012 - Major Depression with Inadequate Response to an Antidepressant Treatment. Phase III.
  • 2014 - 2015 - Major Depression with Inadequate Response to an Antidepressant Treatment. Phase III.
  • Co-investigator
  • 1994 – anxiety disorders III Phase
  • 1997 - major depression III Phase
  • Central Reviewer
  • 2017-2019 MINI in schizophrenia. Phase III.
  • 2019-2020 HAM-D, CGI Major Depression. Phase III.
  • 2020- 2021 MINI, PANSS, BNSS in Schizophrenia. Phase III.
  • 2021 – C-VISA, HAM-D. Depression. Phase III
  • National Language Champion – conductor of training in clinical trials
  • Montgomery Asberg Depression Rating Scale (MADRAS) 2009-2010
  • Young Mania Rating Scale (YMRS) 2009 -2010
  • Research Interview Skills Assessment 2009-2010
  • Positive and Negative Symptoms of Schizophrenia Scale (PANSS) – 1999

Research training:

(Details of any relevant training in the design or conduct of research, for example in the Clinical Trials Regulations, Good Clinical Practice, consent or other training appropriate to non-clinical research. Give the date of the training.)
  • 15 February 2019

Relevant publications:

(Give references to all publications in the last two years plus other publications relevant to the current application.)
  • Cichoń E; Kiejna A; Kokoszka A; Gondek T; Rajba B; Lloyd CE; Sartorius N: Validation of the Polish version of WHO-5 as a screening instrument for depression in adults with diabetes. Diabetes Research And Clinical Practice, 2020, 159, 1-10.
  • Lloyd C.; Sartorius N.; Ahmed H.U.; Alvarez A.; Bahendeka S.; Bobrov A.E.; Burti L.; Chaturvedi S.K.; Gaebel W.; de Girolamo G.; Gondek T.M.; Guinzbourg M.; Heinze M.G.; Khan A.; Kiejna A.; Kokoszka A.; Kamala T.; Lalic N.M.; Lecic-Tosevsk D.; Mannucci E.; Mankovsky B.; Müssig K.; Mutiso V.; Ndetei D.; Nouwen A.; Rabbani, G.; Srikanta S.S.; Starostina E.G.; Shevchuk M.; Taj R.; Valentini U.; van Dam K.; Vukovic O.; Wölwer W.: Factors associated with the onset of Major Depressive Disorder in adults with type 2 diabetes living in 12 different countries; results from the INTERPRET-DD prospective study. Epidemiology and Psychiatric Sciences, 2020, 29, e134, 1–9. https://doi.org/ 10.1017/S2045796020000438
  • Ścigała, D. K., Zdankiewicz- Ścigała, E., Bedyńska, S., and Kokoszka, A. ´(2020). Psychometric properties and configural invariance of the Polish –language version of the 20-item Toronto Ąlexithymia Scale in non-clinical and alcohol addict persons. Front. Psychol. 11:1241. doi: 10.3389/fpsyg.2020. 01241
  • A Kokoszka, E Cichoń, M Obrębski, A Kiejna Cut-off points for Polish-language versions of depression screening tools among patients with Type 2 diabetes. Primary Care Diabetes, 2020 https://doi.org/10.1016/j.pcd.2020.05.015
  • Nouwen A; Adriaanse M; van Dam K; Iversen MM; Viechtbauer W; Peyrot M; Caramlau I; Kokoszka A; Kanc K; de Groot M; Nefs G; Pouwer F; European Depression in Diabetes (EDID) Research Consortium: Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis. Diabetic Medicine, 2019, Vol. 36, pp. 1562-1572. DOI 10.1111/dme.14054
  • Krężołek M., Pionke R., Banaszak B., Kokoszka A., Gawęda Ł.: The relationship between jumping to conclusions and neuropsychological functioning in schizophrenia. Psychiatry Research. 2019; 273: 443-449
  • Berent D., Podgórski M., Kokoszka A. : A need for intervention: Childhood adversities are a significant determinant of health-harming behavior and poor self-efficacy in patients with alcohol dependence. An observational, cross-sectional study on the population of Central Poland. Advances in Clinical and Experimental Medicine. 2018, 27(9):1271-1277
  • Lloyd C. E., Nouwen A., Sartorius N., Ahmed H. U., Alvarez A., Bahendeka S., Basangwa D. , Bobrov A. E., Boden S., Bulgari V., Burti L., Chaturvedi S.K., Cimino L.C., Gaebel W., de Girolamo G., Gondek T. M. , Guinzbourg de Braude M., Guntupalli A., Heinze M.G., Ji L., Hong X., Khan A., Kiejna A., Kokoszka A., Kamala T., Lalic N.M., Lecic Tosevski D., Mankovsky B., Li M., Musau A., Müssig K., Ndetei D., Rabbani G., Srikanta S.S., Starostina E.G., Shevchuk M., Taj R., Vukovic O. , Wölwer W., Xin X. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries. Diabetic Medicine, 2018, 35 (6), 760-769
  • Kokoszka A., Bohaterewicz B., Jeleńska K, Matuszewska, A., Szymański P. : Post-traumatic stress disorder among patients waiting for cardiac surgery. Archives of Psychiatry and Psychotherapy, 2018; 2: 20–25
  • Kokoszka A. Treatment adherence in patients with type 2 diabetes mellitus correlates with different coping styles, low perception of self-influence on disease, and depressive symptoms .Patient Preference and Adherence 2017:11 587–595
  • Kokoszka A.; Sexual dysfunction among women with type 2 diabetes and its relationship with well-being, anxiety and depression. Archives of Psychiatry and Psychotherapy, 2017, 19, 2: 25–31
You can also download the CV
PDF
PDF